Advertisement
CYTK vs NXTC
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CYTK is a Hold and NXTC is a Hold.
CYTK's RSI Oscillator climbs out of oversold territory
The RSI Indicator for CYTK moved out of oversold territory on October 14, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 24 similar instances when the indicator left oversold territory. In 22 of the 24 cases the stock moved higher. This puts the odds of a move higher at 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 50 of 69 cases where CYTK's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 72%.
The Moving Average Convergence Divergence (MACD) for CYTK just turned positive on October 13, 2026. Looking at past instances where CYTK's MACD turned positive, the stock continued to rise in 45 of 57 cases over the following month. The odds of a continued upward trend are 79%.
Following a +3.73% 3-day Advance, the price is estimated to grow further. Considering data from situations where CYTK advanced for three days, in 216 of 296 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.
CYTK may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on September 15, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CYTK as a result. In 83 of 98 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 85%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CYTK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 78%.
The Aroon Indicator for CYTK entered a downward trend on October 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 1 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 62 (best 1 - 100 worst), indicating steady price growth. CYTK’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 74 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CYTK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.
The Tickeron Valuation Rating of 100 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (60.606) is normal, around the industry mean (26.782). CYTK's P/E Ratio (702.500) is considerably higher than the industry average of (43.395). CYTK's Projected Growth (PEG Ratio) (82.230) is slightly higher than the industry average of (9.059). Dividend Yield (0.000) settles around the average of (0.000) among similar stocks. P/S Ratio (128.205) is also within normal values, averaging (437.542).
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
NXTC's MACD Histogram just turned positive
The Moving Average Convergence Divergence (MACD) for NXTC turned positive on October 07, 2026. Looking at past instances where NXTC's MACD turned positive, the stock continued to rise in 37 of 44 cases over the following month. The odds of a continued upward trend are 84%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 06, 2026. You may want to consider a long position or call options on NXTC as a result. In 71 of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 83%.
Following a +9.55% 3-day Advance, the price is estimated to grow further. Considering data from situations where NXTC advanced for three days, in 188 of 233 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
Bearish Trend Analysis
The 10-day RSI Indicator for NXTC moved out of overbought territory on October 12, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 28 similar instances where the indicator moved out of overbought territory. In 22 of the 28 cases, the stock moved lower in the following days. This puts the odds of a move lower at 79%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 48 of 51 cases where NXTC's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 90%.
NXTC moved below its 50-day moving average on October 16, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for NXTC crossed bearishly below the 50-day moving average on September 23, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 81%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NXTC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.
NXTC broke above its upper Bollinger Band on October 07, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 24 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.914) is normal, around the industry mean (26.782). P/E Ratio (0.000) is within average values for comparable stocks, (43.395). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (0.000) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (437.542).
The Tickeron Price Growth Rating for this company is 49 (best 1 - 100 worst), indicating steady price growth. NXTC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NXTC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
CYTK | NXTC | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 71 | 24 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 100 Overvalued | 24 Undervalued | |
PROFIT vs RISK RATING 1..100 | 74 | 100 | |
SMR RATING 1..100 | 100 | 100 | |
PRICE GROWTH RATING 1..100 | 62 | 49 | |
P/E GROWTH RATING 1..100 | 1 | 100 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
NXTC's Valuation (24) in the Biotechnology industry is significantly better than the same rating for CYTK (100). This means that NXTC’s stock grew significantly faster than CYTK’s over the last 12 months.
CYTK's Profit vs Risk Rating (74) in the Biotechnology industry is in the same range as NXTC (100). This means that CYTK’s stock grew similarly to NXTC’s over the last 12 months.
CYTK's SMR Rating (100) in the Biotechnology industry is in the same range as NXTC (100). This means that CYTK’s stock grew similarly to NXTC’s over the last 12 months.
NXTC's Price Growth Rating (49) in the Biotechnology industry is in the same range as CYTK (62). This means that NXTC’s stock grew similarly to CYTK’s over the last 12 months.
CYTK's P/E Growth Rating (1) in the Biotechnology industry is significantly better than the same rating for NXTC (100). This means that CYTK’s stock grew significantly faster than NXTC’s over the last 12 months.
| CYTK | NXTC | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 90% | 2 days ago 79% |
| Stochastic ODDS (%) | 2 days ago 72% | 2 days ago 90% |
| Momentum ODDS (%) | 3 days ago 85% | 2 days ago 83% |
| MACD ODDS (%) | 2 days ago 79% | 2 days ago 84% |
| TrendWeek ODDS (%) | 2 days ago 78% | 2 days ago 86% |
| TrendMonth ODDS (%) | 2 days ago 76% | 2 days ago 85% |
| Advances ODDS (%) | 3 days ago 73% | 3 days ago 81% |
| Declines ODDS (%) | 5 days ago 78% | 5 days ago 86% |
| BollingerBands ODDS (%) | 2 days ago 67% | 2 days ago 85% |
| Aroon ODDS (%) | 2 days ago 85% | N/A |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CYTK’s FA Score shows that 1 FA rating(s) are green while NXTC’s FA Score has 1 green FA rating(s).
- CYTK’s FA Score: 1 green, 4 red.
- NXTC’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CYTK’s TA Score shows that 5 TA indicator(s) are bullish while NXTC’s TA Score has 3 bullish TA indicator(s).
- CYTK’s TA Score: 5 bullish, 3 bearish.
- NXTC’s TA Score: 3 bullish, 6 bearish.
Price Growth
CYTK (@Biotechnology) experienced а -1.53% price change this week, while NXTC (@Biotechnology) price change was -13.09% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -10.78%. For the same industry, the average monthly price growth was -18.33%, and the average quarterly price growth was -21.56%.
Reported Earning Dates
CYTK is expected to report earnings on Oct 29, 2026.
NXTC is expected to report earnings on Oct 29, 2026.
Industries' Descriptions
@Biotechnology (-10.78% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| VGIT | 57.13 | 0.06 | +0.11% |
| Vanguard Intermediate-Term Treasury ETF (VGIT) | |||
| BILZ | 100.81 | 0.04 | +0.04% |
| PIMCO Ultra Short Government Active Exchange-Traded Fund (BILZ) | |||
| HELS | 23.49 | -0.41 | -1.71% |
| Hedgeye 130/30 Equity ETF (HELS) | |||
| SNOY | 9.95 | -0.92 | -8.46% |
| YieldMax SNOW Option Income Strategy ETF (SNOY) | |||
| SNDU | 14.00 | -2.30 | -14.11% |
| T-REX 2X Long SNDK Daily Target ETF (SNDU) | |||
NXTC and
Correlation & Price change
A.I.dvisor indicates that over the last year, NXTC has been loosely correlated with CYTK. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if NXTC jumps, then CYTK could also see price increases.
| Ticker / NAME | Correlation To NXTC | 1D Price Change % | ||
|---|---|---|---|---|
| NXTC | 100% | -9.30% | ||
| CYTK - NXTC | 37% Loosely correlated | -3.08% | ||
| JSPR - NXTC | 36% Loosely correlated | -9.81% | ||
| ORMP - NXTC | 33% Poorly correlated | -2.63% | ||
| GOSS - NXTC | 32% Poorly correlated | -1.35% | ||
| TAOX - NXTC | 28% Poorly correlated | -7.86% | ||
More | ||||